[一季报]润丰股份(301035):2022年第一季度报告全文（英文版）
|
时间：2022年04月28日 00:57:25 中财网 |
|
原标题:润丰股份:2022年第一季度报告全文（英文版）
Stock code:301035 Stock abbreviation: Rainbow Chemical Announcement No.: 2022-014 SHANDONG WEIFANG RAINBOW CHEMICAL CO.,LTD
The First Quarter Report of 2022
The Company and all members of the Board of Directors warrant that the contents of the
Semi-annual Report are true, accurate and complete, without false records, misleading
statements or major omissions.
Important notes:
1. The Board of Directors, Board of Supervisors, directors, supervisors and senior management warrant that the contents of the Quarterly Report are true, accurate and complete, without false records, misleading statements or major omissions, and shall bear individual and collective legal liabilities.
2. The legal representative of the Company, the chief accountant in charge, and the chief of the accounting institution (accounting supervisor), stated that the financial report in the Quarterly Report is true, accurate and complete.
3. Whether the First Quarter Report is audited
□ Yes √ No
I. Key Financial Data
(I) Key Accounting Data and Financial Indicators
Whether the Company needs to retroactively adjust or restate the accounting data of previous years □ Yes √ No
| | Q1 2022 | Q1 2021 | Year-on-year increase or
decrease | | Operating income (RMB) | 3,119,046,203.43 | 1,811,987,233.25 | 72.13% | | Net profit attributable to shareholders of
the Company (RMB) | 387,571,013.34 | 96,143,598.31 | 303.12% | | Net profit attributable to shareholders of
the Company excluding non-recurring
gains and losses (RMB) | 389,050,777.23 | 83,683,638.61 | 364.91% |
| Net cash flow from operating activities
(RMB) | -224,220,205.58 | -385,771,636.97 | 41.88% | | Basic earnings per share (RMB/Share) | 1.40 | 0.46 | 204.35% | | Diluted earnings per share (RMB/Share) | 1.39 | 0.46 | 202.17% | | Weighted average return on net assets | 7.62% | 3.37% | 4.25% | | | End of Q1 2022 | End of 2021 | Year-on-year increase or
decrease | | Total assets (RMB) | 10,478,339,575.02 | 10,311,655,543.89 | 1.62% | | Equity attributable to shareholders of the
Company (RMB) | 5,282,959,850.40 | 4,908,724,302.71 | 7.62% |
(II) Items and Amounts of Non-recurring Gains and Losses
√ Applicable □ Not applicable
Unit: RMB
| Item | Amount of Q1 2022 | Notes | | Gain and loss on disposal of non-current assets (including the
write-off portion of asset impairment provision) | -8,890,722.01 | | | Government subsidies included in current gains and losses
(closely related to normal operational business of the Company,
excluding the continuous government subsidies of certain
amount or quota complying with national policies) | 3,083,662.79 | | | Other non-operating revenue and expenditure other than those
mentioned above | 3,746,190.86 | | | Less: affected amount of income tax | -626,920.87 | | | Affected amount of minority shareholders' equity (after
tax) | 45,816.40 | | | Total | -1,479,763.89 | -- |
Other gains and losses items that meet the definition of non-recurring gains and loss: □ Applicable √ Not applicable
There are no other gains and losses items of the Company that meet the definition of non-recurring gains and loss.
Reasons for the non-recurring profit and loss items listed in Explanatory Announcement on Information Disclosure for Companies
Offering Their Securities to the Public No.1 - Non-recurring Gains and Losses recognized as recurring gains and losses items
□ Applicable √ Not applicable
There is no circumstance where the non-recurring profit and loss items listed in Explanatory Announcement on Information
Disclosure for Companies Offering Their Securities to the Public No.1 - Non-recurring Gains and Losses are recognized as recurring
gains and losses items.
(III) Changes to Key Accounting Data and Financial Indicators and Reasons √ Applicable □ Not applicable
1、Balance Sheet
Unit: RMB
| Item | March 31, 2022 | December 31,
2021 | Change | Reason for change | | Receivables financing | 930,000.00 | 100,000.00 | 830.00% | Mainly caused by increase in bank acceptance notes received
during the reporting period | | Other receivables | 15,993,073.04 | 11,576,269.72 | 38.15% | Mainly caused by increase in travel allowance for overseas
business personnel during the reporting period | | Right-of-use assets | 25,374,525.12 | 18,876,699.07 | 34.42% | Mainly caused by the assets recognized by the lease warehouse
during the reporting period | | Goodwill | 51,285,150.10 | 26,949,350.10 | 90.30% | Mainly caused by the increase of the number of companies not
under the same control acquired through merger of controlling
interests during the reporting period | | Deferred income tax
assets | 70,489,777.12 | 46,893,086.34 | 50.32% | Mainly caused by increase in offset of unrealized internal trading
gains and losses during the reporting period |
| Other non-current
assets | 45,340,010.54 | 130,713,116.29 | -65.31% | Mainly caused by written-off prepayments during the reporting
period | | Contract liabilities | 125,369,343.29 | 45,096,633.96 | 178.00% | Mainly caused by advance payments of subsidiaries | | Lease liability | 19,205,317.92 | 13,312,230.04 | 44.27% | Mainly caused by the debt recognized by the lease warehouse
during the reporting period | | Other comprehensive
income | -36,853,204.89 | -6,390,755.46 | -476.66% | Mainly caused by changes in difference from translation of
statements during the reporting period |
2. Income Statement
Unit: RMB
| Item | January-March 2022 | January-March
2021 | Change | Reason for change | | Operating income | 3,119,046,203.43 | 1,811,987,233.25 | 72.13% | Mainly caused by business growth during the reporting
period | | Operating cost | 2,407,497,426.79 | 1,572,034,075.13 | 53.15% | Mainly caused by cost growth due to revenue growth during
the reporting period | | Sales expenses | 46,948,661.90 | 29,879,244.83 | 57.13% | Mainly caused by increase in staff remuneration and
registration fees during the reporting period | | Management expenses | 95,729,283.94 | 55,848,194.81 | 71.41% | Mainly caused by increase in equity incentive expenses
during the reporting period | | R&D expenditures | 89,023,043.97 | 39,604,702.74 | 124.78% | Mainly caused by increase in investment of R&D during the
reporting period | | Financial expenses | 39,787,968.31 | 3,263,065.59 | 1119.34% | Mainly caused by increase in exchange losses during the
reporting period | | Other income | 830,854.19 | 10,175,944.89 | -91.84% | Mainly caused by the reduction in government subsidies
received related to daily business activities during the
reporting period | | Investment returns | 28,854,869.96 | 69,851,489.39 | -58.69% | Mainly caused by decrease in proceeds from forward
exchange settlement business during the reporting period | | Income from changes in
fair value | 7,793,443.00 | -65,032,162.30 | 111.98% | Mainly caused by proceeds from changes in fair value of
forward exchange settlement business during the reporting
period | | Credit impairment
losses | -27,370,228.25 | -5,368,653.39 | -409.82% | Mainly caused by increase in provision for bad debt
reserves during the reporting period | | Asset impairment losses | -82,433.27 | 436,876.42 | -118.87% | Mainly caused by increase in accrued provision for
inventory depreciation during the reporting period | | Non-operating expenses | 10,541,457.40 | 1,018,048.89 | 935.46% | Mainly caused by increase in scrapped fixed assets during
the reporting period | | Income tax expenses | 50,034,413.97 | 16,473,904.54 | 203.72% | Mainly caused by increase in profits during the reporting
period |
II. Shareholder Information
(I) The number of common shareholders, the number of preferred shareholders whose voting rights have
been restored and the shareholdings of the top ten shareholders Unit: Share
| Number of common shareholders as of the end
of Q1 2022 | 8,573 | Number of preferred
shareholders whose
voting rights have been
restored as of the end of
Q1 2022 (if any) | 0 | | | | | Shareholding of the top ten shareholders | | | | | | | | Name of shareholder | Shareholder
nature | Sharehold
ing ratio | Shareholdin
g quantity | Quantity of
restricted
shares held | Pledge, mar | or freeze | | | | | | | Share status | Quantity | | Shandong Rainbow
Investment Co., Ltd | Domestic
non-state-owned
legal person | 41.61% | 114,911,237 | 114,911,237 | Pledge | 23,301,837 |
| KONKIA INC. | Overseas legal
person | 22.16% | 61,191,800 | 61,191,800 | | | | Shandong Rainbow
Agrosciences Investment
Co., Ltd. | Domestic
non-state-owned
legal person | 4.75% | 13,105,690 | 13,105,690 | | | | XingDaFa technology
(ShenZhen) Co., Ltd. | Domestic
non-state-owned
legal person | 2.99% | 8,264,487 | 8,264,487 | | | | Jinan Xinbo Investment
Co., Ltd. | Domestic
non-state-owned
legal person | 2.84% | 7,856,786 | 7,856,786 | Pledge | 7,856,786 | | Industrial and
Commercial Bank of
China Co., Ltd. -
BOCOM Schroder Trend
Priority Hybrid Securities
Investment Fund | Other | 1.41% | 3,906,664 | 0 | | | | Guotai Fund - Bank of
Communications - Guotai
Fund Boyuan No. 20
Collective Assets
Management Plan | Other | 1.26% | 3,479,997 | 0 | | | | China Construction Bank
Corporation - Guotai
Great Health Equity
Securities Investment
Fund | Other | 1.03% | 2,831,892 | 0 | | | | Bank of Communications
Co., Ltd. - Guotai Jinying
Growth and Flexibly
Allocated Hybrid
Securities Investment
Fund | Other | 0.73% | 2,002,728 | 0 | | | | Shandong Agricultural
University Education
Development Foundation | Domestic
non-state-owned
legal person | 0.65% | 1,800,000 | 1,800,000 | | | | Shareholding of top ten shareholders of unrestricted shares | | | | | | | | Name of shareholder | Quantity of unrestricted shares held | Type of shares | | | | | | | | Type of shares | Quantity | | | | | Industrial and Commercial Bank of China Co.,
Ltd. - BOCOM Schroder Trend Priority
Hybrid Securities Investment Fund | 3,906,664 | RMB-denomin
ated common
shares | 3,906,664 | | | | | Guotai Fund - Bank of Communications -
Guotai Fund Boyuan No. 20 Collective Assets
Management Plan | 3,479,997 | RMB-denomin
ated common
shares | 3,479,997 | | | | | China Construction Bank Corporation - Guotai
Great Health Equity Securities Investment
Fund | 2,831,892 | RMB-denomin
ated common
shares | 2,831,892 | | | | | Bank of Communications Co., Ltd. - Guotai
Jinying Growth and Flexibly Allocated Hybrid
Securities Investment Fund | 2,002,728 | RMB-denomin
ated common
shares | 2,002,728 | | | | | Guotai Fund - Bank of Shanghai - Guotai
Fund Gewu No. 2 Collective Assets
Management Plan | 1,557,538 | RMB-denomin
ated common
shares | 1,557,538 | | | | | Yuanxin (Zhuhai) Private Equity Fund
Management Co., Ltd. - Citic Capital China
Value Growth No. 1 Private Securities
Investment Fund | 1,538,914 | RMB-denomin
ated common
shares | 1,538,914 | | | | | Yuanxin (Zhuhai) Private Equity Fund | 1,368,857 | RMB-denomin | 1,368,857 | | | |
| Management Co., Ltd. - Citic Capital China
Value Growth No. 3 Private Securities
Investment Fund | | ated common
shares | | | China Merchants Bank Co., Ltd. - BOCOM
Schroder Qicheng Hybrid Securities
Investment Fund | 1,289,935 | RMB-denomin
ated common
shares | 1,289,935 | | China CITIC Bank Corporation Limited -
Hua'an Jujia Selected Mixed Securities
Investment Fund | 1,225,625 | RMB-denomin
ated common
shares | 1,225,625 | | Yuanxin (Zhuhai) Private Equity Fund
Management Co., Ltd. - Citic Capital China
Value Growth Private Securities Investment
Fund | 1,168,866 | RMB-denomin
ated common
shares | 1,168,866 | | Explanation of the above-mentioned
shareholder relationship or concerted action | Shandong Rainbow Investment Co., Ltd., KONKIA INC and Shandong
Runnong Investment Co., Ltd. are enterprises controlled by Wencai Wang,
Guoqing Sun and Hongbing Qiu, the actual controllers of the Company The
Company does not know whether the above-mentioned other shareholders are
associated or are persons acting in concert. | | | | Engagement of the top 10 shareholders in
securities margin trading business (if any) | Not applicable | | |
(II) The number of preferred shareholders of the Company and the shareholdings of the top ten preferred
shareholders
□ Applicable √ Not applicable
(III) Changes in restricted shares
√ Applicable □ Not applicable
Unit: Share
| Name of shareholder | Starting number
of restricted
shares in
reporting period | Decreased
number of
restricted
shares in
reporting
period | Increased
number of
restricted
shares in
reporting
period | Closing
number of
restricted
shares in
reporting
period | Type for
restricted shares | Proposed date
of the removal
of restrictions | | Shandong Rainbow
Investment Co., Ltd | 114,911,237 | 0 | 0 | 114,911,237 | Pre-IPO
restricted shares | 2024-7-28 | | KONKIA INC | 61,191,800 | 0 | 0 | 61,191,800 | Pre-IPO
restricted shares | 2024-7-28 | | Shandong Rainbow
Agrosciences
Investment Co., Ltd. | 13,105,690 | 0 | 0 | 13,105,690 | Pre-IPO
restricted shares | 2024-7-28 | | XingDaFa technology
(ShenZhen) Co., Ltd. | 8,264,487 | 0 | 0 | 8,264,487 | Pre-IPO
restricted shares | 2022-7-28 | | Jinan Xinbo
Investment Co., Ltd. | 7,856,786 | 0 | 0 | 7,856,786 | Pre-IPO
restricted shares | 2022-7-28 | | Shandong Agricultural
University Education
Development
Foundation | 1,800,000 | 0 | 0 | 1,800,000 | Pre-IPO
restricted shares | 2022-7-28 | | Post-IPO offline
placement restricted
shares | 3,559,355 | 3,559,355 | | 0 | Post-IPO offline
placement
restricted shares | 2022-1-28 | | Total | 210,689,355 | 3,559,355 | 0 | 207,130,000 | -- | -- |
Note: 1. If a shareholder owns restricted shares as of the end of the reporting period, it is imperative to state the type for restricted
shares in the “Type for restricted shares” column, and the proposed date of the removal of restrictions in the “Proposed date of the
2. In the case of a large number of shareholders with restricted shares, it is suggested that the changes in holdings of restricted shares
by the top ten shareholders are disclosed in detail, and that the changes in holdings of restricted shares by other shareholders are
presented in consolidated list.
III. Other important matters
□ Applicable √ Not applicable
IV. Quarterly Financial Statements
(I) Financial Statements
1. Consolidated balance sheet
Prepared by: Shandong Weifang Rainbow Co., Ltd.
March 31, 2022
Unit: RMB
| Item | Closing balance | Opening balance | | Current assets: | | | | Monetary funds | 3,463,454,228.77 | 3,724,744,059.71 | | Deposit reservation for balance | | | | Lending to banks and other
financial institutions | | | | Financial assets held for trading | 200,000,000.00 | 200,000,000.00 | | Derivative financial assets | 56,715,726.50 | 48,922,283.50 | | Notes receivable | 33,727,790.11 | 35,385,609.76 | | Accounts receivable | 2,830,006,971.92 | 2,328,358,879.35 | | Receivables financing | 930,000.00 | 100,000.00 | | Pre-payments | 91,522,985.08 | 77,313,374.04 | | Premium receivable | | | | Re-insurance accounts
receivable | | | | Reserves for re-insurance
contract receivable | | | | Other receivables | 15,993,073.04 | 11,576,269.72 | | Including: Interest receivable | | | | Dividends receivable | | | | Financial assets purchased under
resale agreement | | | | Inventory | 1,579,075,681.41 | 1,775,113,092.67 | | Contracted assets | | | | Assets held for sale | | | | Non-current assets that mature
within one year | | | | Other current assets | 232,186,373.52 | 264,431,341.13 | | Total current assets | 8,503,612,830.35 | 8,465,944,909.88 | | Non-current assets: | | |
| Disbursed loans and advances | | | | Debt investments | | | | Other debt investment | | | | Long-term receivables | | | | Long-term equity investment | 1,655,956.49 | 1,810,538.69 | | Other equity instrument
investment | | | | Other non-current financial
assets | | | | Investment properties | | | | Fixed assets | 1,331,519,747.06 | 1,218,635,770.03 | | Construction in progress | 322,202,255.49 | 281,855,456.95 | | Productive biological assets | | | | Oil and gas assets | | | | Right-of-use assets | 25,374,525.12 | 18,876,699.07 | | Intangible assets | 124,550,584.21 | 118,003,684.46 | | Development expenditure | | | | Goodwill | 51,285,150.10 | 26,949,350.10 | | Long-term deferred expenses | 2,308,738.54 | 1,972,932.08 | | Deferred income tax assets | 70,489,777.12 | 46,893,086.34 | | Other non-current assets | 45,340,010.54 | 130,713,116.29 | | Total non-current assets | 1,974,726,744.67 | 1,845,710,634.01 | | Total assets | 10,478,339,575.02 | 10,311,655,543.89 | | Current liabilities: | | | | Short-term borrowings | 557,628,021.04 | 550,348,417.31 | | Borrowings from the central
bank | | | | Borrowings from banks and
financial institutions | | | | Financial liabilities held for
trading | | | | Derivative financial liabilities | | | | Notes payable | 2,908,931,832.36 | 3,369,427,627.30 | | Accounts payable | 1,062,192,873.43 | 879,276,036.26 | | Advance payments | | 2,624,536.52 | | Contract liabilities | 125,369,343.29 | 45,096,633.96 | | Financial assets sold for
repurchase | | | | Deposits and interbank deposits
received | | | | Amount received from agency
trading of securities | | | | Amount received from agency
underwriting of securities | | | | Payroll payable | 113,218,860.66 | 154,700,982.42 | | Taxes payable | 98,980,144.24 | 83,154,482.55 | | Other payables | 38,535,978.12 | 29,657,941.65 |
| Including: Interests payable | | | | Dividends payable | | | | Handling charges and
commissions payable | | | | Re-insurance accounts payable | | | | Liabilities held for sale | | | | Non-current liabilities due
within one year | 17,958,747.62 | 19,679,032.26 | | Other current liabilities | 31,611,529.03 | 37,357,003.10 | | Total current liabilities | 4,954,427,329.79 | 5,171,322,693.33 | | Non-current liabilities: | | | | Provision for insurance contracts | | | | Long-term borrowings | 22,307,482.32 | 25,555,537.87 | | Bonds payable | | | | Including: Preferred shares | | | | Perpetual bonds | | | | Lease liability | 19,205,317.92 | 13,312,230.04 | | Long-term payables | | | | Long-term payroll payable | | | | Accrued liabilities | 840,000.00 | 840,000.00 | | Deferred income | 13,756,949.92 | 13,950,734.80 | | Deferred income tax liabilities | 45,808,186.55 | 43,570,565.25 | | Other non-current liabilities | | | | Total non-current liabilities | 101,917,936.71 | 97,229,067.96 | | Total liabilities | 5,056,345,266.50 | 5,268,551,761.29 | | Owner’s equity: | | | | Share capital | 276,180,000.00 | 276,180,000.00 | | Other equity instruments | | | | Including: Preferred shares | | | | Perpetual bonds | | | | Capital reserve | 2,239,904,753.76 | 2,226,848,878.76 | | Less: Treasury sshares | | | | Other comprehensive income | -36,853,204.89 | -6,390,755.46 | | Special reserve | 18,854,594.41 | 14,783,485.63 | | Surplus reserve | 158,674,657.07 | 158,674,657.07 | | General risk reserve | | | | Undistributed profit | 2,626,199,050.05 | 2,238,628,036.71 | | Total owners' equity attributed to the
parent company | 5,282,959,850.40 | 4,908,724,302.71 | | Minority interest | 139,034,458.12 | 134,379,479.89 | | Total owner’s equity | 5,421,994,308.52 | 5,043,103,782.60 | | Total liabilities and owners’ equity | 10,478,339,575.02 | 10,311,655,543.89 |
Legal Representative: Wicky Wang Chief Accountant in Charge: Xing Bingpeng Chief of Accounting Institution: Zhang Baolin
2. Consolidated income statement
Unit: RMB
| Item | Amount incurred in Q1 2022 | Amount incurred in Q4 2021 | | I. Gross Operating Income | 3,119,046,203.43 | 1,811,987,233.25 | | Including: Operating income | 3,119,046,203.43 | 1,811,987,233.25 | | Interest income | | | | Premium earned | | | | Handling charges and
commissions income | | | | II. Total Operating Costs | 2,683,271,106.81 | 1,703,919,011.52 | | Including: Operating costs | 2,407,497,426.79 | 1,572,034,075.13 | | Interest expenses | | | | Handling charges and
commission expenses | | | | Surrender value | | | | Net payments for
insurance claims | | | | Net withdrawal of reserve
for insurance responsibility contracts | | | | Expenditures of policy
dividend | | | | Re-insurance expenses | | | | Taxes and surcharges | 4,284,721.90 | 3,289,728.42 | | Sales expenses | 46,948,661.90 | 29,879,244.83 | | Management expenses | 95,729,283.94 | 55,848,194.81 | | R&D expenditures | 89,023,043.97 | 39,604,702.74 | | Financial expenses | 39,787,968.31 | 3,263,065.59 | | Including: Interest
expenses | 3,963,794.98 | 6,900,132.63 | | Interest income | 12,370,112.07 | 7,559,060.48 | | Add: Other income | 830,854.19 | 10,175,944.89 | | Income from investment (“-”
for loss) | 28,854,869.96 | 69,851,489.39 | | Including: Income from
investments in associated enterprises
and joint ventures | -154,582.20 | 19,635.23 | | Income recognized at
termination of financial assets
measured at amortized cost | | | | Foreign exchange gain ("-"
for loss) | | | | Net exposure hedging
income ("-" for loss) | | | | Income from changes in fair
value ("-" for loss) | 7,793,443.00 | -65,032,162.30 | | Credit impairment losses ("-"
for loss) | -27,370,228.25 | -5,368,653.39 | | Asset impairment losses ("-"
for loss) | -82,433.27 | 436,876.42 |
| Gains from asset disposal
("-" for loss) | | 48,006.49 | | III. Operating Profit ("-" for loss) | 445,801,602.25 | 118,179,723.23 | | Add: Non-operating income | 7,403,049.27 | 5,524,461.42 | | Less: Non-operating expenses | 10,541,457.40 | 1,018,048.89 | | IV. Total Profit Before Tax (“-” for
total losses) | 442,663,194.12 | 122,686,135.76 | | Less: Income tax expenses | 50,034,413.97 | 16,473,904.54 | | V. Net Profit ("-" for net loss) | 392,628,780.15 | 106,212,231.22 | | (I) Classification by business
continuity | | | | 1. Net profit from continuing
operations (“-” for net loss) | 392,628,780.15 | 106,212,231.22 | | 2. Net profit from discontinued
operations (“-” for net loss) | | | | (II) Classification by ownership | | | | 1. Net profit attributable to the
owners of the parent company | 387,571,013.34 | 96,143,598.31 | | 2. Profit or loss of minority
shareholders | 5,057,766.81 | 10,068,632.91 | | VI. Net Amount after Tax of Other
Comprehensive Income | -30,865,238.01 | -36,369.05 | | Net amount of other comprehensive
income after tax attributed to the
owners of the parent company | -30,462,449.43 | 168,282.40 | | (I) Other comprehensive income
that cannot be reclassified into profits
or losses | | | | 1. Changes due to
re-measurement on defined benefit
plan | | | | 2. Other comprehensive
income that cannot be converted into
profit and loss under the equity method | | | | 3. Changes in fair value of
other equity instrument investments | | | | 4. Changes in the fair
value of the credit risk of the enterprise | | | | 5. Other | | | | (ii) Other comprehensive income
that will be reclassified into profits or
losses | -30,462,449.43 | 168,282.40 | | 1. Other comprehensive
income that can be converted to profits
or losses under the equity method | | | | 2. Changes in fair value
for other investment on bonds | | | | 3. Amount of financial
assets reclassified into other
comprehensive income | | | | 4. Provision for credit
impairment of other debt investments | | | | 5. Cash flow hedge reserve | | | | 6. Difference of foreign | -30,462,449.43 | 168,282.40 |
|
